［1］ Hashimoto Y,Shindo-Okada N,Tani M,et al.Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display［J］.Cancer Res,1996,56(22):5266-5271.
［2］ Xu L,Corcoran RB,Welsh JW,et al.WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene［J］.Genes Dev,2000,14(5):585-595.
［3］ Su F,Overholtzer M,Besser D,et al.WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase［J］.Genes Dev,2002,16(1):46-57.
［4］ Pennica D,Swanson TA,Welsh JW,et al.WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors［J］.Proc Natl Acad Sci USA,1998,95(25):14717-14722.
［5］ Clausen MJ,Melchers LJ,Mastik MF,et al.Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma［J］.Genes Chromosomes Cancer,2016,55(1):45-59.
［6］ Nagai Y,Watanabe M,Ishikawa S,et al.Clinical significance of Wnt-induced secreted protein-1 (WISP-1/CCN4) in esophageal squamous cell carcinoma［J］.Anticancer Res,2011,31(3):991-997.
［7］ Zhang H,Luo H,Hu Z,et al.Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation［J］.Oncotarget,2015,6(8):6218-6234.
［8］ Yang JY,Yang MW,Huo YM,et al.High expression of WISP-1 correlates with poor prognosis in pancreatic ductal adenocarcinoma［J］.Am J Transl Res,2015,7(9):1621-1628.
［9］ Gurbuz I,Ferralli J,Roloff T,et al.SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients［J］.Mol Cancer,2014,13:22.
［10］ Jiang Shanshan,Xin Yan.Research progress of WISP1 and tumors［J］.Modern Oncology,2018,26(10):1639-1642.
［11］ Chiang KC,Yeh CN,Chung LC,et al.WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer［J］.Sci Rep,2015,5:8686.
［12］ Xie D,Nakachi K,Wang H,et al.Elevated levels of connective tissue growth factor,WISP-1,and CYR61 in primary breast cancers associated with more advanced features［J］.Cancer Res,2001,61(24):8917-8923.
［13］ Wu J,Long Z,Cai H,et al.High expression of WISP1 in colon cancer is associated with apoptosis,invasion and poor prognosis［J］.Oncotarget,2016,7(31):49834-49847.
［14］ Tian C,Zhou ZG,Meng WJ,et al.Overexpression of connective tissue growth factor WISP-1 in Chinese primary rectal cancer patients［J］.World J Gastroenterol,2007,13(28):3878-3882.
［15］ Davies SR,Davies ML,Sanders A,et al.Differential expression of the CCN family member WISP-1,WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications［J］.Int J Oncol,2010,36(5):1129-1136.
［16］ Gerdes J,Lemke H,Baisch H,et al.Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67［J］.J Immunol,1984,133(4):1710-1715.
［17］ Kloppel G,La Rosa S.Ki67 labeling index:Assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms［J］.Virchows Arch,2017,472(3):341-349.
［18］ Huang G,Chen S,Wang D,et al.High Ki67 expression has prognostic value in surgically-resected T3 gastric adenocarcinoma［J］.Clin Lab,2016,62(1-2):141-153.
［19］ Min KW,Kim DH,Son BK,et al.A High Ki67/BCL2 index could predict lower disease-free and overall survival in intestinal-type gastric cancer［J］.Eur Surg Res,2017,58(3-4):158-168.
［20］ Badary DM,Abdel-Wanis ME,Hafez MZ,et al.Immunohistochemical analysis of PTEN,HER2/neu,and ki67 expression in patients with gastric cancer and their association with survival［J］.Pathophysiology,2017,24(2):99-106.
［21］ Richardsen E,Andersen S,Al-Saad S,et al.Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort［J］.PLoS One,2017,12(11):e186852.